Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset

Journal of Autoimmunity

Volumn 18, Issue 1, 2002, Pages 49-53

  Hampe, Christiane S ^a   Hammerle, Lisa P ^a   Bekris, Lynn ^a   Örtqvist, Eva ^b   Persson, Bengt ^b   Lernmark, Åke ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Autoimmunity; Epitopes; GAD65; GAD67; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CHILD; DIABETES MELLITUS; DISEASE COURSE; HLA TYPING; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0037006434     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2001.0564     Document Type: Article

References (29)

1. r autoantibodies as predictors of insulin-dependent diabetes
2. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
3. Insulin antibodies in insulin-dependent diabetics before insulin treatment
4. Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512)
5. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases
6. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years
7. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function
8. Persistence of antibodies to a 64,000-Mr islet cell protein after onset of type 1 diabetes
9. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children
10. Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of type 1 diabetes
11. Recognition of Glutamic Acid Decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes
12. Species-specific autoantibodies in type 1 diabetes
13. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
14. 3H recombinant human ligands
15. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs
16. Radioimmunological determination of C-peptide in serum
17. Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetes children followed for two years from their clinical diagnosis
18. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes
19. Restriction fragment length polymorphism analysis of HLA-DRB, DQA and DQB genes in South Indians and Swedish Caucasians
20. The development of a World Health Organisation international standard for islet cell antibodies: The aims and design of an international collaborative study
21. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies epitopes in childhood IDDM
22. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes
23. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target difference epitopes
24. Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes
25. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes
26. Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children
27. HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients
28. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children
29. Associations of GAD65- and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings